PolyPid Ltd. Ordinary Shares Stock Prediction
AI-powered sentiment analysis and prediction trends for PYPD, updated each market day.
PYPD AI Sentiment
AI sees no strong directional signal for PolyPid Ltd. Ordinary Shares stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About PolyPid Ltd. Ordinary Shares
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. The company's product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
Exchange
Market Cap
$83,393,741
Cap Tier
Employees
75
Listed Since
June 26, 2020
Website
PYPD Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
PYPD Volatility
PolyPid Ltd. Ordinary Shares has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
